Introduction Effects of AD Agitation Agitation Treatment Options Antipsychotics and AD CATIEAD Discontinuing Antipsychotics Provisional Definition of Agitation Agitation Epidemiology Case 1 ID: 658555
Download Presentation The PPT/PDF document "Best Practices in the Identification and..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Best Practices in the Identification and Management of Alzheimer Agitation Slide2Slide3
IntroductionSlide4
Effects of AD AgitationSlide5
Agitation Treatment OptionsSlide6
Antipsychotics and ADSlide7
CATIE-ADSlide8
Discontinuing AntipsychoticsSlide9
Provisional Definition of AgitationSlide10
Agitation EpidemiologySlide11
Case 1Slide12
Case 1 (cont)Slide13
Behavioral ChangeSlide14
Case 2Slide15
Case 2 (cont)Slide16
Selecting TherapySlide17
Diagnosis: NPISlide18
Diagnosis: APA Guideline RecommendationsSlide19
ScalesSlide20
Treatment: APA Guideline RecommendationsSlide21
Pharmacologic TherapySlide22
Investigational Therapies: DM/QSlide23
Investigational Therapies: DM/Q (cont)Slide24
Investigational Therapies: PimavanserinSlide25
Investigational Therapies: Cannabinoids Slide26
Investigational Therapies: CitalopramSlide27
ConclusionsSlide28
Abbreviations